Limitless X Holdings (LIMX) EBIT Margin (2020 - 2026)
Limitless X Holdings' (LIMX) quarterly EBIT Margin came in at 6748.21% in Q2 2026, down 649133.0% year-over-year from N/an in Q2 2025, and down 353.85% quarter-over-quarter from 1486.88% in Q1 2026.
Analysis
Limitless X Holdings (LIMX) EBIT Margin (2020 - 2026) Analysis & Trends
Limitless X Holdings has disclosed EBIT Margin across 7 years of filings, most recently posting 6748.21% for Q2 2026.
- In Q2 2026, EBIT Margin fell 649133.0% year-over-year to 6748.21%; the TTM figure through Jun 2026 stood at 1581.92% (down 108664.0% YoY), while the FY2025 annual figure was 961.82%, down 84612.0% from the prior year.
- EBIT Margin came in at 6748.21% for Q2 2026 at Limitless X Holdings, down from 1486.88% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 452.64% in Q4 2023 to a low of 6748.21% in Q2 2026.
- Average EBIT Margin over 5 years is 739.78%, with a median of 89.01% recorded in 2024.
- Year-over-year, EBIT Margin jumped 49895 bps in 2023 and slumped 649133 bps in 2026.
- Over 5 years, EBIT Margin stood at 46.31% in 2022, then jumped by 1078 bps to 452.64% in 2023, then plunged by 226 bps to 568.26% in 2024, then slumped by 248 bps to 1978.91% in 2025, then slumped by 241 bps to 6748.21% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 6748.21% in Q2 2026, 1486.88% in Q1 2026, and 1978.91% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | 18.95% |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | 17.67% |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | 15.11% |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | 14.27% |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | - |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | 2.30% |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | 4.39% |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | 9.67% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Limitless X Holdings | 11.84 Mn | 11.84 Mn | 30,160.00 | -6,748.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,748.21% |
| Mar 31, 2026 | -1,486.88% |
| Dec 31, 2025 | -1,978.91% |
| Sep 30, 2025 | -501.07% |
| Jun 30, 2025 | -256.88% |
| Mar 31, 2025 | -1,679.81% |
| Dec 31, 2024 | -568.26% |
| Sep 30, 2024 | -82.69% |
| Jun 30, 2024 | -37.08% |
| Mar 31, 2024 | -95.33% |
| Dec 31, 2023 | 452.64% |
| Sep 30, 2023 | -119.76% |
| Jun 30, 2023 | -61.13% |
| Mar 31, 2023 | -52.10% |
| Dec 31, 2022 | -46.31% |
| Sep 30, 2022 | -12.73% |
| Jun 30, 2022 | -46.23% |
| Mar 31, 2022 | 4.69% |
| Dec 31, 2021 | 9.12% |
| Sep 30, 2021 | -70.50% |